Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 5731734, 8 pages
http://dx.doi.org/10.1155/2016/5731734
Research Article

The Association between C9orf72 Repeats and Risk of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis: A Meta-Analysis

Xiangya Hospital, Central South University, Hunan, China

Received 27 January 2016; Accepted 4 April 2016

Academic Editor: Jan Aasly

Copyright © 2016 Li Shu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Vance, A. Al-Chalabi, D. Ruddy et al., “Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3,” Brain, vol. 129, no. 4, pp. 868–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. DeJesus-Hernandez, I. R. Mackenzie, B. F. Boeve et al., “Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS,” Neuron, vol. 72, no. 2, pp. 245–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Iguchi, M. Katsuno, K. Ikenaka, S. Ishigaki, and G. Sobue, “Amyotrophic lateral sclerosis: an update on recent genetic insights,” Journal of Neurology, vol. 260, no. 11, pp. 2917–2927, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Liu, J.-T. Yu, Y. Zong, J. Zhou, and L. Tan, “C9ORF72 mutations in neurodegenerative diseases,” Molecular Neurobiology, vol. 49, no. 1, pp. 386–398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Renton, E. Majounie, A. Waite et al., “A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD,” Neuron, vol. 72, no. 2, pp. 257–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Nuytemans, G. Bademci, M. M. Kohli et al., “C9orf72 intermediate repeat copies are a significant risk factor for Parkinson disease,” Annals of Human Genetics, vol. 77, no. 5, pp. 351–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. P. E. A. Ash, K. F. Bieniek, T. F. Gendron et al., “Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS,” Neuron, vol. 77, no. 4, pp. 639–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. D. Freibaum, Y. Lu, R. Lopez-Gonzalez et al., “GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport,” Nature, vol. 525, no. 7567, pp. 129–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Zhang, C. J. Donnelly, A. R. Haeusler et al., “The C9orf72 repeat expansion disrupts nucleocytoplasmic transport,” Nature, vol. 525, no. 7567, pp. 56–61, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Zu, Y. Liu, M. Bañez-Coronel et al., “RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 51, pp. E4968–E4977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. N. Smith, S. Newhouse, A. Shatunov et al., “The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder,” European Journal of Human Genetics, vol. 21, no. 1, pp. 102–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Stewart, N. J. Rutherford, H. Briemberg et al., “Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p,” Acta Neuropathologica, vol. 123, no. 3, pp. 409–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Kohli, K. John-Williams, R. Rajbhandary et al., “Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians,” Neurobiology of Aging, vol. 34, no. 5, pp. 1519.e5–1519.e12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Beck, M. Poulter, D. Hensman et al., “Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population,” The American Journal of Human Genetics, vol. 92, no. 3, pp. 345–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Majounie, Y. Abramzon, A. E. Renton et al., “Repeat expansion in C9ORF72 in Alzheimer's disease,” The New England Journal of Medicine, vol. 366, no. 3, pp. 283–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Gijselinck, T. Van Langenhove, J. van der Zee et al., “A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study,” The Lancet Neurology, vol. 11, no. 1, pp. 54–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-Y. Zou, X.-G. Li, M.-S. Liu, and L.-Y. Cui, “Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients,” Neurobiology of Aging, vol. 34, no. 6, pp. 1710.e5–1710.e6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-P. Yang, M.-H. Hyun, J.-M. Yoon, M.-J. Park, D. Kim, and S. Park, “Association between TNF-α-308 G/A gene polymorphism and gastric cancer risk: a systematic review and meta-analysis,” Cytokine, vol. 70, no. 2, pp. 104–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Harms, B. A. Benitez, N. Cairns et al., “C9orf72 hexanucleotide repeat expansions in clinical alzheimer disease,” JAMA Neurology, vol. 70, no. 6, pp. 736–741, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Cacace, C. Van Cauwenberghe, K. Bettens et al., “C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment,” Neurobiology of Aging, vol. 34, no. 6, pp. 1712–e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Jiao, J.-F. Guo, Y.-Q. Wang et al., “C9orf72 mutation is rare in Alzheimer's disease, Parkinson's disease, and essential tremor in China,” Frontiers in Cellular Neuroscience, vol. 7, article 164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-H. Lin, T.-F. Chen, M.-J. Chiu, H.-I. Lin, and R.-M. Wu, “Lack of C9orf72 repeat expansion in Taiwanese patients with mixed neurodegenerative disorders,” Frontiers in Neurology, vol. 5, article 59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Rollinson, N. Halliwell, K. Young et al., “Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease,” Neurobiology of Aging, vol. 33, no. 8, pp. 1846.e5–1846.e6, 2012. View at Google Scholar · View at Scopus
  25. A. Wojtas, K. A. Heggeli, N. Finch et al., “C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic,” American Journal of Neurodegenerative Disease, vol. 1, no. 1, pp. 107–118, 2012. View at Google Scholar
  26. Z. Xi, L. Zinman, Y. Grinberg et al., “Investigation of C9orf72 in 4 neurodegenerative disorders,” Archives of Neurology, vol. 69, no. 12, pp. 1583–1590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Borghero, M. Pugliatti, F. Marrosu et al., “Genetic architecture of ALS in Sardinia,” Neurobiology of Aging, vol. 35, no. 12, pp. 2882.e7–2882.e12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Brettschneider, V. M. Van Deerlin, J. L. Robinson et al., “Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion,” Acta Neuropathologica, vol. 123, no. 6, pp. 825–839, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Byrne, M. Elamin, P. Bede et al., “Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study,” The Lancet Neurology, vol. 11, no. 3, pp. 232–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Chiò, G. Borghero, G. Restagno et al., “Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72,” Brain, vol. 135, no. 3, pp. 784–793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Cooper-Knock, C. Hewitt, J. R. Highley et al., “Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72,” Brain, vol. 135, no. 3, pp. 751–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Debray, V. Race, V. Crabbé et al., “Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study,” Neurobiology of Aging, vol. 34, no. 12, pp. 2890.e7–2890.e12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. A. Dombroski, D. R. Galasko, I. F. Mata et al., “C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex,” JAMA Neurology, vol. 70, no. 6, pp. 742–745, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. A. García-Redondo, O. Dols-Icardo, R. Rojas-García et al., “Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide,” Human Mutation, vol. 34, no. 1, pp. 79–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Jiao, B. Tang, X. Liu et al., “Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China,” Neurobiology of Aging, vol. 35, no. 4, pp. 936–e22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. K. P. Kenna, R. L. McLaughlin, S. Byrne et al., “Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing,” Journal of Medical Genetics, vol. 50, no. 11, pp. 776–783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Konno, A. Shiga, A. Tsujino et al., “Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 4, pp. 398–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Millecamps, S. Boillée, I. Le Ber et al., “Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes,” Journal of Medical Genetics, vol. 49, no. 4, pp. 258–263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Ogaki, Y. Li, N. Atsuta et al., “Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis,” Neurobiology of Aging, vol. 33, no. 10, pp. 2527.e11–2527.e6, 2012. View at Google Scholar · View at Scopus
  40. A. Ratti, L. Corrado, B. Castellotti et al., “C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect,” Neurobiology of Aging, vol. 33, no. 10, pp. e7–e14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. N. J. Rutherford, M. G. Heckman, M. DeJesus-Hernandez et al., “Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype,” Neurobiology of Aging, vol. 33, no. 12, pp. 2950.e5–2950.e7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Sabatelli, F. L. Conforti, M. Zollino et al., “C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population,” Neurobiology of Aging, vol. 33, no. 8, pp. 1848.e15–1848.e20, 2012. View at Publisher · View at Google Scholar
  43. C.-P. Tsai, B.-W. Soong, P.-H. Tu et al., “A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan,” Neurobiology of Aging, vol. 33, no. 9, pp. 2232.e11–2232.e18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Van Laere, A. Vanhee, J. Verschueren et al., “Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study,” JAMA Neurology, vol. 71, no. 5, pp. 553–561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. W. van Rheenen, M. van Blitterswijk, M. H. B. Huisman et al., “Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases,” Neurology, vol. 79, no. 9, pp. 878–882, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Van Der Zee, K. Sleegers, and C. V. Broeckhoven, “Invited article: the Alzheimer disease-frontotemporal lobar degeneration spectrum,” Neurology, vol. 71, no. 15, pp. 1191–1197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Alavi, S. Nafissi, M. Rohani et al., “Repeat expansion in C9ORF72 is not a major cause of amyotrophic lateral sclerosis among iranian patients,” Neurobiology of Aging, vol. 35, no. 1, pp. 267.e1–267.e7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Gijselinck, S. van Mossevelde, J. van der Zee et al., “The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar · View at Scopus